Case Report
Copyright ©The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 100724
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.100724
Advanced pancreatic cancer treated with camrelizumab combined with apatinib: A case report
Yun-Hao Luo, Ting He, Lu Lin, Rong-Qiu Wang, Hong-Xia Cai, Wen Hu
Yun-Hao Luo, Department of Critical Care Medicine, Chengdu First People's Hospital, Chengdu 610000, Sichuan Province, China
Ting He, Department of Radiology, Sichuan Second Hospital of Traditional Chinese Medicine, Chengdu 610000, Sichuan Province, China
Lu Lin, Rong-Qiu Wang, Hong-Xia Cai, Department of Oncology, Chengdu Seventh People's Hospital, Chengdu 610000, Sichuan Province, China
Wen Hu, Department of Oncology, West China Tianfu Hospital, Sichuan University, Chengdu 610000, Sichuan Province, China
Author contributions: Luo YH contributed to the writing of the original draft; He T was involved in editing the manuscript and medical image analysis; Lin L, Wang RQ and Cai HX participated in manuscript editing and provided computed tomography images; Hu W was mainly responsible for writing and reviewing the manuscript.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: The authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Wen Hu, MM, Doctor, Department of Oncology, West China Tianfu Hospital, Sichuan University, No. 3966 South Second Section, Tianfu Avenue, Tianfu New District, Chengdu 610000, Sichuan Province, China. huwenzhongliu@163.com
Received: August 24, 2024
Revised: November 1, 2024
Accepted: December 4, 2024
Published online: February 15, 2025
Processing time: 146 Days and 21.5 Hours
Core Tip

Core Tip: Pancreatic cancer (PC) is among the most lethal malignancies worldwide, with minimal advancements in treatment over the past three decades. We report the case of a patient with highly malignant PC who demonstrated a poor response to chemotherapy. However, immunotherapy and targeted therapy extended the patient's progression-free survival and improved her quality of life. Immunotherapy and targeted therapy may offer new hope for PC patients.